| scholarly article | Q13442814 |
| P50 | author | Sankar Navaneethan | Q109544900 |
| P2093 | author name string | Stacey E Jolly | |
| Jesse D Schold | |||
| Susana Arrigain | |||
| Joseph V Nally | |||
| P2860 | cites work | A new equation to estimate glomerular filtration rate | Q24651973 |
| Long-term mortality after gastric bypass surgery | Q28241874 | ||
| Chronic kidney disease and mortality risk: a systematic review | Q28243131 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| Prevalence of chronic kidney disease in the United States | Q29614191 | ||
| Deaths: preliminary data for 2011. | Q30834439 | ||
| Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar | Q33721299 | ||
| The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. | Q33852363 | ||
| Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis | Q34124206 | ||
| CKD and the risk of incident cancer | Q34259993 | ||
| Development and validation of an electronic health record-based chronic kidney disease registry | Q34497258 | ||
| Relation between kidney function, proteinuria, and adverse outcomes | Q34659683 | ||
| Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 | ||
| Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. | Q34927050 | ||
| Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). | Q35165502 | ||
| Long-term trends in adult mortality for U.S. Blacks and Whites: an examination of period- and cohort-based changes | Q35572000 | ||
| Association of CKD and cancer risk in older people | Q37211112 | ||
| Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study | Q37248468 | ||
| Association between urinary albumin excretion and coronary heart disease in black vs white adults | Q37334750 | ||
| White/black racial differences in risk of end-stage renal disease and death | Q37357909 | ||
| Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002-2010). | Q38422461 | ||
| Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States | Q39281813 | ||
| The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort | Q44392359 | ||
| Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States | Q44625416 | ||
| Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies | Q44853464 | ||
| Accuracy of death certificate diagnosis of intracranial hemorrhage and nonhemorrhagic stroke. The Minnesota Heart Survey | Q44933088 | ||
| Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. | Q45934250 | ||
| Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. | Q46004523 | ||
| Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease | Q46365320 | ||
| Race and renal impairment in heart failure: mortality in blacks versus whites | Q46381116 | ||
| Racial variations in quality of care and outcomes in an ambulatory heart failure cohort | Q46626964 | ||
| Kidney function as a predictor of noncardiovascular mortality | Q46776022 | ||
| Age affects outcomes in chronic kidney disease. | Q51107585 | ||
| Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 | Q64111843 | ||
| Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization | Q79811373 | ||
| Let's get serious about racial and ethnic disparities | Q81399207 | ||
| Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP) | Q85763914 | ||
| P433 | issue | 10 | |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 2512-2520 | |
| P577 | publication date | 2015-06-04 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Cause-Specific Deaths in Non-Dialysis-Dependent CKD | |
| P478 | volume | 26 |
| Q57286170 | A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease |
| Q90701836 | Albuminuria, Kidney Function, and Cancer Risk in the Community |
| Q35993577 | Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study |
| Q43274572 | Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES). |
| Q36237997 | Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease |
| Q98289114 | Association of hypertriglyceridemic waist phenotype with renal function impairment: a cross-sectional study in a population of Chinese adults |
| Q48054525 | Associations of dysnatremias with mortality in chronic kidney disease |
| Q43085110 | BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues |
| Q38656898 | Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease |
| Q36591446 | Body mass index and causes of death in chronic kidney disease |
| Q90507204 | Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation |
| Q90437924 | Cause-specific mortality in the general population with transient dipstick-proteinuria |
| Q46362140 | Causes of Death after a Hospitalization with AKI. |
| Q61815820 | Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project |
| Q36193259 | Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study |
| Q36106852 | Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease |
| Q53697731 | Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study. |
| Q31141059 | Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie. |
| Q92338516 | Management of small renal masses in patients with chronic kidney disease: Perspectives from a nephrologist |
| Q90470119 | Microalbuminuria and cardiorenal risk: old and new evidence in different populations |
| Q36692766 | Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease |
| Q43236768 | Not All Deaths in CKD Are from a Broken Heart. |
| Q28387680 | Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012 |
| Q38837256 | Oxalate, inflammasome, and progression of kidney disease |
| Q89160493 | Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy |
| Q94528610 | Targeting Vascular Calcification in Chronic Kidney Disease |
| Q39031609 | The effect of chronic kidney disease on T cell alloimmunity |
| Q89072601 | Treatment of Hypertension in Chronic Kidney Disease |
Search more.